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Abstract
Computational models of the heart, from cell-level models, through one-
, two- and three-dimensional tissue-level simplifications, to biophysically-
detailed three-dimensional models of the ventricles, atria or whole heart,
allow the simulation of excitation and propagation of this excitation, and
have provided remarkable insight into the normal and pathological function-
ing of the heart. In this article we present equations for modelling cellular
excitation (i.e. the cell action potential) from both a phenomenological and a
biophysical perspective. Hodgkin-Huxley formalism is discussed, along with
the current generation of biophysically-detailed cardiac cell models. Alterna-
tive Markovian formulations for modelling ionic currents are also presented.
Equations describing propagation of this cellular excitation, through one-,
two- and three-dimensional idealised or realistic tissues, are then presented.
For all types of model, from cell to tissue, methods for discretisation and in-
tegration of the underlying equations are discussed. The article finishes with
a discussion of two tissue-level experimental imaging techniques – diffusion
tensor magnetic resonance imaging and optical imaging – that can be used
to provide data for parameterisation and validation of cell- and tissue-level
cardiac models.
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1. Introduction1
The physiological purpose of the heart is to function as a reliable, rhyth-2
mic pump to maintain the circulation of blood through the body for the3
duration of our life. Although the heart is a mechanical pump, this mechan-4
ical activity is driven by electrical activity through the process of excitation-5
contraction coupling [1–3]. During normal sinus rhythm, an electrical wave6
initiates in the sinoatrial node, then propagates through the two atria before7
being delayed at the atrioventricular node. The excitation wavefront then8
moves along the His-Purkinje conducting system before exciting the endocar-9
dial surfaces of the ventricles. The electrical wave then propagates transmu-10
rally towards the epicardial ventricular surface, exciting the entire ventricles.11
Thus the atria contract before the ventricles, with these two contractions12
forming the rhythmic cardiac cycle. If this normal rhythm is disturbed (a13
cardiac arrhythmia), electrical activity is no longer synchronised, mechanical14
activity therefore fails to synchronise, effective pumping of the blood ceases15
and death may occur.16
The study of such arrhythmias has been a major focus of computational17
biology, as a detailed quantitative description of cardiac electrophysiology18
has been developed that allows the simulation of both normal and patho-19
logical excitation and propagation of this excitation [4, 5]. Additionally, the20
results of such simulations can be dissected in time and space, and by param-21
eters, allowing a detailed study at the cell and tissue levels of the mechanisms22
underlying arrhythmias [6, 7]. Experimental studies of cardiac arrhythmias23
at the tissue level have been largely limited to voltage recordings on or near24
the surface of a preparation [8] or by using multiple plunge electrodes within25
the heart [9], and so computational studies offer an additional research tool.26
However, a model is, by definition, a simplification of a system, and so simula-27
tions are a trade-off between model complexity and computational efficiency,28
especially at the tissue and organ levels.29
Nevertheless, models do not only describe physiological behaviour, they30
are predictive, and have provided remarkable insight into the normal and31
pathological functioning of the heart [10–17]. One focus of computational32
cardiac modelling is understanding the interaction between cell-level arrhyth-33
mia triggers (such as early and delayed afterdepolarisations) and tissue-level34
substrates (such as spatially heterogeneous refractory periods, or the my-35
ocyte disarray seen with pathologies such as heart failure) that enable these36
triggers to develop into re-entrant cardiac arrhythmias (e.g. [18–21]). Due37
2
to technical and ethical limitations associated with animal and human ex-38
periments, computational models have played a crucial role in allowing us to39
understand these interactions.40
Here we present monodomain equations and finite difference methods to41
simulate cell- and tissue-level electrophysiology (readers interested in other42
techniques such as bidomain equations and finite element methods are re-43
ferred to references [4, 17, 22–24]). Although this article focusses on mod-44
elling cell- and tissue-level electrophysiology in ventricular tissue, the same45
principles apply to modelling electrophysiology in other types of cardiac cells46
and tissues (e.g. atrial [25]). This paper is Part 2 of a two-part article (see47
Colman et al. in this issue for Part 1); open-source code from the Leeds48
Computational Physiology Laboratory, covering the modelling presented in49
both parts of this article, is available in the Multi-scale Cardiac Simulation50
Framework from http://www.physicsoftheheart.com/.51
2. Modelling Ventricular Myocyte Electrophysiology52
Detailed mathematical and computational models of ventricular cell elec-53
trophysiology, constructed using experimentally obtained data and further54
validated against experimental results, provide tools for understanding ex-55
citation processes, both normal and abnormal, at the cellular level. The56
models reconstruct the ionic membrane currents and dynamic ion concen-57
tration changes that underlie the ventricular action potential, and form one58
component of the biophysically detailed models reconstructing propagation59
in the ventricles.60
2.1. Ionic gradients; equilibrium and reversal potentials61
The flow of an ion across the cell membrane through an open ion channel62
depends on the intra- and extracellular concentrations of that ion, and the63
membrane potential. Suppose that two reservoirs contain the same ion B but64
at different concentrations. Ion B has a positive charge. Each reservoir also65
contains another ion, S, with a negative charge and at concentrations such66
that each reservoir is, at least initially, electrically neutral. The two reservoirs67
are separated by a semi-permeable membrane that allows B to pass but not S.68
As the membrane is permeable to B, B will tend to move across the membrane69
down its concentration gradient. However, as S cannot cross the membrane70
there is a build up of negative charge in the reservoir from which B is moving.71
This build up of charge acts as an attracting force, opposing the movement72
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of B down its concentration gradient. The net gradient – i.e. the sum of the73
electrical and chemical gradients – is called the electrochemical gradient, and74
there comes a point when the force of the concentration gradient is exactly75
opposed by the force of the electrical gradient such that the electrochemical76
gradient is zero, and net movement of ion B through the membrane will stop.77
The voltage at which this occurs is known as the equilibrium potential, Eeq78










where R = 8.314 J.K−1.mol−1 is the universal gas constant, T is absolute80
temperature (K), z is the valency of the ion, F = 96485 C.mol−1 is Faraday’s81
constant, and [B]i and [B]o are the intra- and extracellular concentrations of82
ion B, respectively. For given intra- and extracellular ionic concentrations,83
an equilibrium potential exists for each ionic species. The electrochemical84
gradient for a particular ionic species is the difference between the membrane85
potential and the equilibrium potential, V −Eeq, and the sign of this gradient86
determines the direction of the flow of ions. Assuming that only one ionic87
species can flow across the membrane, the electrochemical gradient causes88
V to move towards Eeq. When V = Eeq there will be no net flow, and89
changing V past Eeq will cause the electrochemical gradient, and therefore90
the direction of the flow of ions, to reverse.91
Equilibrium potentials are not, however, properties of ion channels, al-92
though if a particular channel is only permeable to one ionic species, then93
the reversal potential, Erev, of that channel (the potential at which there is94
no net flux through the open channel) will be the same as the equilibrium95
potential for that ion. However, channels are often permeable to more than96
one ionic species (the L-type Ca2+ channel, for example, which is permeable97
to Ca2+, Na+ and K+), and the reversal potential of the current in such cases98
will be the result of several equilibrium potentials. The Goldman-Hodgkin-99
Katz (GHK) voltage equation is used to calculate the reversal potential in100















where PB is the permeability of the channel to ion B. The GHK equation102
























Figure 1: Phases of the action potential in endocardial (left) and epicardial (right) my-
ocytes. The epicardial action potential shows a characteristic spike-and-dome morphology,
which is attenuated in endocardial cells. The midmyocardial action potential morphology
is similar to that in epicardial cells, but with a longer action potential duration (∼7–31%
longer in non-failing human tissue [26]). Action potentials shown here were simulated
using the Luo-Rudy model [27] at a basic cycle length of 500 ms.
direction in which the membrane potential will move if the permeabilities104
of ionic species are altered (e.g. through ion channel gating). From the105
GHK equation we can see that the membrane potential will tend to move106
towards the equilibrium potential of the ionic species whose permeability107
is the greatest, as the equilibrium potential of that ion will dominate Erev.108
For example, when a cardiac myocyte is at rest, PK ≫ PNa and so the109
membrane potential V moves towards (although not all the way to) EK, which110
is approximately −90 mV and near the resting membrane potential. When111
the cell is depolarised past threshold, PNa ≫ PK and so V moves from its112
resting value towards ENa, which is at a positive potential of approximately113
80 mV and so results in phase 0 depolarisation and an action potential.114
2.2. The Ventricular Action Potential115
The ventricular action potential is a transient change in the potential116
across a cell membrane (see Fig. 1) that propagates throughout the ventri-117
cles to trigger contraction of the ventricular muscle. The ventricular action118
potential can be broken down into distinct phases, each of which is associated119
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with specific ionic currents which differ not only in different regions of the120
heart but in different regions of the ventricular tissue. Phase 0, the upstroke,121
is the initial rapid depolarisation of the membrane to a positive potential.122
In epicardial and midmyocardial cells, there is then a rapid phase 1 repo-123
larisation that is absent in endocardial cells. A plateau in the membrane124
potential (phase 2) then occurs before a final stage of repolarisation (phase125
3). Phase 4 is the resting membrane potential. The presence of phase 1 re-126
polarisation in epicardial and midmyocardial gives rise to the characteristic127
spike and dome morphology of action potentials recorded from these cells.128
The action potential is an all-or-none event, such that a perturbation to the129
membrane potential that takes it from its resting level past a threshold will130
result in phase 0 depolarisation. This all-or-none response is characteristic131
of a wide range of physical, chemical and biological systems, including nerve132
and muscle, and is termed excitability. The action potential is determined133
by a complex interplay between several ionic membrane currents, pumps and134
exchangers, with different directions (i.e. inwards or outwards), magnitudes135
and kinetics that determine their time course and effect on the action po-136
tential morphology (see Fig. 2). Here, a brief overview of the principal ionic137
currents found in ventricular myocytes, and their relation to the phases of138
the action potential, is given; a detailed review can be found in [28].139
Sodium currents: There are two principal Na+ currents in ventricular my-140
ocytes. As the Na+ concentration is greatest outside the cell and the reversal141
potential of the currents is greater than maximum membrane potential, the142
Na+ currents are always inward, at least under physiological conditions. The143
major Na+ current is the fast inward current, INa, which is responsible for144
the rapid phase 0 upstroke of the action potential. INa has a relatively large145
amplitude and is both voltage- and time-dependent. It is controlled by three146
processes – an activation gate and two inactivation gates, one of which has147
rapid kinetics and one having slower kinetics. The kinetics of the activation148
and fast inactivation gates result in INa activating and inactivating in only a149
few milliseconds. The slow inactivation gate is responsible for the channel’s150
slow recovery from inactivation. At resting membrane potential INa is zero,151
but activates when the membrane potential is raised to approximately −60152
mV by current flowing from neighbouring cells when in vivo or by a stimulus153
current in isolated cells. The second Na+ current is the late Na+ current,154
INa,L. This current has a smaller amplitude than INa but the inactivation155
kinetics are slower, having a time constant of around 600 ms [30]. INa,L has156











































































Figure 2: The action potential (A), intracellular calcium transient (B), and time course of
the principal membrane currents in the ventricular myocyte: (C) Na+ currents, note the
rescaling of INa,L; (D) Ca
+ currents; (E) K+ currents, note the rescaling; (F) pump and
exchanger currents. See text for details. All were simulated at a basic cycle length of 800
ms using the Hund-Rudy epicardial model [29] with the exception of ICa,T, which is from
the Luo-Rudy model [27] and was scaled to match the Hund-Rudy model action potential
duration
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form in epicardial, midmyocardial and endocardial regions of the ventricle158
[31].159
Calcium currents: There are two types of Ca2+ channels in ventricular160
myocytes; L-type (the L indicating a “long-lasting” current with a “large161
conductance”) and T-type (the T indicating “transient opening” and “tiny162
conductance”). Both channels have a high selectivity for Ca2+ and, as Ca2+ is163
at a higher concentration outside compared to inside the cell and the reversal164
potential is more positive than the maximum membrane potential, both are165
inward currents. The current through the L-type channels, ICa,L, is larger166
than that through the T-type channels, ICa,T, and the two currents have167
different voltage dependencies and kinetics: ICa,L activates at around −40168
mV while ICa,T activates at more negative potentials, e.g. approximately169
−60 mV [32, 33]. ICa,L is both voltage- and time-dependent, and also has170
Ca2+-dependent inactivation and so inactivates in response to a rise in Ca2+171
on the intracellular side of the channel. The flow of Ca2+ ions through the172
channel causes a large release of Ca2+ from the sarcoplasmic reticulum (SR),173
a large intracellular Ca2+ store. This process is known as Ca2+-induced174
Ca2+ release (CICR) and is responsible for the rise of intracellular Ca2+ (the175
Ca2+ transient) and the consequent tension development in the cell. This is176
the process of excitation-contraction coupling [1–3]. ICa,L is also responsible177
for maintaining the membrane potential plateau during phase 2 of the action178
potential. The physiological role of ICa,T in ventricular myocytes is less clear,179
although in the sino-atrial and atrioventricular nodes of the heart it is partly180
responsible for pacemaker activity [34].181
Potassium currents: K+ currents show the most electrophysiological vari-182
ation of the major ionic currents in the heart, in that there are many different183
types of K+ currents carried by different channels; here only the major K+184
currents will be considered. K+ concentration is greatest inside the cell and185
the reversal potential is negative compared to resting membrane potential,186
and so K+ currents are outward currents under physiological conditions. IK1187
is the time-independent or inward rectifier current, and in ventricular my-188
ocytes is responsible for maintaining the resting membrane potential. IK1189
shows little time dependence and is active over a wide range of membrane190
potentials. The current reverses at EK ≈ −90 mV. At membrane potentials191
negative to this the current is inward, although under physiological condi-192
tions the membrane potential never drops below this value. The outward193
currents at membrane potentials positive to −90 mV show inward rectifi-194
cation. The transient outward K+ current, Ito1, is responsible for phase 1195
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repolarisation and the spike and dome morphology seen in epicardial and196
midmyocardial ventricular myocytes [35]. The current is not seen at any197
significant magnitude in endocardial cells (e.g. [36]) and so this current,198
along with IKs (see below) and to a lesser extent several other currents, is199
responsible for transmural heterogeneities in electrophysiology. The delayed200
rectifier current is composed of two major parts – a rapid component, IKr,201
and a slow component, IKs [37]. The relative densities of the two currents202
vary between species. In guinea pig for example, IKs is larger [37] while in203
canine, IKr is the largest [38]. The currents oppose the depolarisation drive204
of ICa,L (that maintains the action potential plateau) and are therefore re-205
sponsible for phase 3 repolarisation; as such, they have a significant influence206
on action potential duration. Loss-of-function mutations to KvLQT1, MinK207
and HERG genes cause down-regulation of IKs and IKr, leading to long QT208
syndromes 1 and 2 [39]. Along with Ito1, IKs is a major determinant of209
transmural heterogeneities of electrophysiology.210
Pumps and exchangers: The flow of ions through Na+, Ca2+ and K+ chan-211
nels causes dynamic changes in the intra- and extracellular concentrations212
of these ions. These changes are counteracted by the actions of the Na+-K+213
ATPase and the Na+-Ca2+ exchanger, both of which are electrogenic and214
therefore contribute to the action potential. The Na+-K+ ATPase hydroly-215
ses adenosine triphosphate (ATP) to produce energy and pump Na+ and K+216
up their concentration gradients. Three Na+ ions are carried out of the cell217
for every two K+ ions brought in, and so the net flux of ions results in the218
Na+-K+ ATPase current, INaK, being outward. The Na
+-Ca2+ exchanger can219
operate in forward or reverse modes. In forward mode (sometimes referred220
to as “normal mode”) the exchanger uses the Na+ concentration gradient221
to move three Na+ ions into the cell, and one Ca2+ ion is extruded. The222
exchanger is therefore electrogenic and in forward mode the exchanger cur-223
rent, INaCa, is depolarising. However, the protein can be reversed depending224
on the Na+ and Ca2+ concentrations and on the membrane potential. At225
resting concentrations, the reversal potential of the current is between −40226
and −20 mV and, as membrane potential is around −80 mV, the exchanger227
operates in forward mode and an inward current is produced. During the228
fast upstroke of phase 0 depolarisation, membrane potential becomes more229
positive than the reversal potential and the current reverses, extruding three230
Na+ ions for every Ca2+ ion brought in. During the plateau phase of the231
action potential, intracellular Ca2+ concentration rises (the Ca2+ transient)232







Figure 3: (A) Schematic diagram of the cell membrane, showing the lipid bilayer and
transmembrane proteins (e.g. ion channels, pumps, exchangers). Modified from [40]. (B)
Electrical circuit model of the cell membrane, with the variable resistor representing ion
channels, pumps and exchangers, and the capacitor representing the lipid bilayer
Ca2+ transient. The reversal potential then is more positive than membrane234
potential and INaCa again operates in forward mode to extrude Ca
2+ brought235
into the cell. INaCa therefore changes direction during the course of an action236
potential.237
2.3. The Cell Membrane as an Electrical Circuit238
The cell membrane is organised as a phospholipid bilayer, arranged so239
that the hydrophobic tails of the lipids lie together in the middle of the240
membrane while the hydrophilic heads form the outside of the membrane241
and are in contact with the aqueous solution of the intra- and extracellular242
spaces. Proteins (e.g. ion channels, pumps and exchangers) span this lipid243
bilayer to allow the passage of ions (Fig. 3A). As the membrane is an insu-244
lating material separating regions of charge (i.e. the intra- and extracellular245
spaces) then it can be thought of as a capacitor, with the ion channels, pumps246
and exchangers through the membrane thought of as variable resistors. The247
membrane can therefore be modelled as an electrical circuit with a capaci-248
tor (the lipid bilayer) and a variable resistor (the ion channels) in parallel249
(Fig. 3B). Current can flow through the circuit either through the resistor250
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(the ionic current) or by charging the membrane capacitance (the capacitive251
current). The charge across the capacitor, Q, is the product of capacitance252
and the voltage necessary to hold the charge:253
Q = CmV . (3)
Since the capacitive current in Fig. 3B is dQ/dt (current is charge per unit254
time) and the magnitude of the capacitor, Cm, is constant (at 1 µF.cm
−2 for255
a cardiac cell membrane), then if equation (3) is differentiated with respect256







it can be seen that the capacitive current dQ/dt can also be expressed as258
CmdV/dt. Since the flow of charge between the inside and outside of the259
membrane must be conserved, then from Kirchhoff’s current law the sum of260









= −Iion . (6)
Therefore, the rate of change of the membrane potential, dV/dt, is deter-263
mined by the sum of the ionic currents, Iion. We can model an ionic current264
Ii with a linear instantaneous current-voltage relationship as265
Ii = gi(V − Erev) , (7)
where gi is the channel conductance and V −Erev is the electrochemical gradi-266
ent. In order to model an action potential – a transient change in membrane267
potential – using equations (6) and (7), a suitable form for Iion and the con-268
ductances gi must be determined. This was first described quantitatively for269
the squid giant axon by Hodgkin and Huxley in 1952.270
2.4. Hodgkin-Huxley Formalism271
In a series of five papers published in the Journal of Physiology in 1952272
[41–45], Alan Hodgkin and Andrew Huxley, along with Bernard Katz who273
was a co-author on the first paper and a collaborator in several related stud-274
ies, determined the dynamics of the ionic conductances that determine the275
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action potential in the squid giant axon. They utilised the experimental276
procedures of space clamping (inserting a thin metallic conductor along the277
length of the axon in order to provide low axial resistance and remove any278
spatial gradients in membrane potential) and voltage clamping (applying a279
feedback current to the cell in order to keep the membrane potential at a280
specified value, the command potential), both recently developed by Ken-281
neth Cole and George Marmont with colleagues. (For a history and review282
of the experimental and mathematical background to the Hodgkin-Huxley283
model, see [46, 47].) Here, the method of describing channel gating using284
Hodgkin-Huxley formalism will be described. This formalism is still used in285
the current generation of biophysically detailed models, yet it is perhaps best286
to describe it in the context of the original Hodgkin-Huxley model.287
It has already been shown that a cell membrane may be modelled as a288
capacitor in parallel with an ionic current (equation 6). Hodgkin and Huxley289
identified that, in the squid giant axon, the principal ionic currents are the290
Na+ and K+ currents, and that the other smaller currents, composed mainly291
of the Cl− current, could be lumped together into a single “leakage” current.292




= −INa − IK − IL − Istim , (8)
where INa is the sodium current, IK is the potassium current, IL is the leakage294
current and Istim is any applied stimulus current. Furthermore, since the295
single channel instantaneous I-V curves for open Na+ and K+ channels in296
the squid giant axon are approximately linear, each current can be written as297
the product of a conductance, g, and a driving force V −Erev as in equation298
(7), where Erev is the reversal potential of the current which is given by299
the Nernst equation (1). Note that by using the equilibrium potentials for300
the respective channel reversal potentials, it is assumed that the channels are301
selective for only one ionic species. It was also assumed that gL was constant,302
such that gL = ḡL, where ḡL is the maximal leakage current conductance.303




= −gNa(V − ENa)− gK(V − EK)− ḡL(V − EL)− Istim . (9)
As the influx of Na+ and the efflux of K+ were found to be small during an305







Figure 4: Schematic diagram of a simple gating scheme. The channel oscillates between
open and closed states with the rate constants α and β. This gating scheme is not repre-
sentative of actual channel structure and function, yet it is a useful model that allows the
mathematical reconstruction of gating kinetics
all ionic concentrations were constant. As such, the equilibrium potentials307
are also constant.308
In order to solve equation (9) it is necessary to determine the conduc-309
tances gNa and gK, which vary with membrane potential and time. For a310
unit area of membrane (1 cm2 in the case of the Hodgkin-Huxley model),311
any conductance g can be given as the product of the single channel con-312
ductance, γ, the number of channels per unit area of membrane, N , and the313
open probability of a single channel, Popen where 0 ≤ Popen ≤ 1, which is the314
same as the fraction of the channels in the open state. Therefore315
g = γNPopen . (10)
The maximal conductance per unit area of membrane, ḡ, is determined by γ316
and N , which are constants:317
ḡ = γN , (11)
and so equation (10) can be written as318
g = ḡPopen . (12)
The conductances are therefore the product of a maximal conductance, ḡ,319
which is a constant, and the probability of a channel being in the open state,320
Popen, which is determined by gating variables.321
Suppose a simple channel is assumed to be controlled by a single charged322
gate (i.e. the gate is voltage-dependent) that can be in either a closed or an323
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open state (see Fig. 4) that moves between the two states with an opening324





(Note that channels can be controlled by more than one gating process,326
as described later, but here it is simpler and more intuitive to assume a327
single gating process. Note also that the gating mechanism is not necessarily328
voltage-dependent, but could be mediated by chemical signals such as ionic329
concentrations, as for L-type calcium current inactivation, or by mechanical330
stimuli, as with stretch-activated channels.) The probability that the channel331
will be open, Popen, is the same as the fraction of the total N channels in332
the open position, k, and so we can say Popen = k. If all of the N channels333
are open, k = 1, if all the channels are closed, k = 0. If k is the fraction of334
channels in the open state, then because the number of channels is constant,335
1− k is the fraction of channels in the closed state, and the rates of opening336
and closing are therefore337
Rate of opening = αk(1− k) , (13)
338
Rate of closing = βkk . (14)
The net rate of change of the fraction of channels in the open state is the339
difference between these rates of opening and closing, and so340
dk
dt
= αk(1− k)− βkk . (15)
It is this differential equation that is used to describe a gating mechanism.341
To see how the equation works, suppose that the membrane potential is342
at some voltage V0 and the gating variable k is at a steady-state value k0343
appropriate to this voltage. The rate coefficients αk and βk also have values344
appropriate to the voltage V0. If V0 is stepped to a new voltage then αk and345
βk instantaneously take on the new values appropriate to this new voltage346
and the differential equation (15) determines how k0 approaches its new value347
k∞. The solution to the differential equation (15) is348












where τk is a voltage-dependent time constant. The steady-state function351
for k, equation (17), can be derived by substituting dk/dt = 0 and k∞ = k352
into equation (15) and rearranging with respect to k∞. The time constant353
τk is the reciprocal of the sum of the rate coefficients. Equation (16) shows354
that, upon stepping to a new voltage, k will change from its old value k0355
and approach its new value k∞ with an exponential time course. The rate356
coefficients αk and βk determine how quickly k approaches its new value: if357
the sum of αk and βk is large then τk will be small and the rate of change358
will be fast, and vice versa.359
However, it is still necessary to experimentally determine the voltage-360
dependent rate coefficients αk and βk. To do this, an experimental voltage-361
clamp protocol is utilised such that values of αk and βk can be determined362
at specific voltages. From macroscopic current traces when V is clamped to363
a new voltage, k∞ and τk can be determined and αk and βk for the specific364










which are derived from equations (17) and (18). Values of αk and βk can367
then be plotted as functions of the membrane potential at which they were368
recorded, and an equation fitted to these data in order to obtain continuous369
functions of αk and βk. It is this protocol that Hodgkin and Huxley utilised370
when determining the time course of the conductances gNa and gK during an371
action potential, and which will now be described.372
For the Hodgkin-Huxley model, it is perhaps easier to start with the K+373
conductance gK, as only a single process is involved. Figures 5A and B show374
experimental voltage clamp recordings (open circles) of the K+ conductance375
from [45]. In Fig. 5A, the membrane is depolarised and the conductance gK376
follows a sigmoidal increase to its new value. Upon depolarisation, gK follows377
an exponential decrease to its original value. Hodgkin and Huxley modelled378
this conductance by raising a single gating process as described above to the379







Figure 5: Experimentally recorded conductance changes in squid giant axon (open circles)
and solutions to the Hodgkin-Huxley equations (smooth curves), as functions of time. (A)
Response of K+ conductance to a step increase in membrane potential, followed by a step
decrease. (B) Responses of K+ conductance to step increases in membrane potential of
varying magnitudes. The ordinate scale is identical for curves A to J , but is increased
fourfold for curvesK and L for clarity. (C) Responses of Na+ conductance to step increases
in membrane potential of varying magnitudes. Ordinate scale bars are shown on the right.
Each trace in panel B and C is labelled with the magnitude of the step voltage v from
resting membrane potential in mV (i.e. V = Vrest + v). From [45].
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where ḡK is the maximal K
+ conductance (which is also determined from381
the experimental recordings), and n is the fraction of K+ channels in the382
open state (also known as the K+ channel gating variable). This equation is383
analogous to equation (12) described earlier. Raising n to the fourth power384
was not chosen for any physiological reason, but simply because it gave the385
best fit to the experimental data. The differential equation describing the386
rate of change of n is therefore387
dn
dt
= αn(1− n)− βnn . (22)
As described before, the solution to this equation is388
n = n∞ − (n∞ − n0) exp(−t/τn) , (23)










To construct continuous functions of αn and βn, values for n∞ and τn were de-391
termined at specific voltages from the experimental results shown in Fig. 5B,392
utilising a form of equation (23) along with equation (21) that was suitable393












with gK0 the initial conductance at t = 0, and gK∞ the conductance at the end395
of the voltage pulse. The value for n∞ at a particular voltage was then given396
by gK∞, as a fraction of the maximal gK∞ attained during all the voltage397
clamp experiments, with τn for a particular voltage chosen to give the best398
fit to the experimental data. (Although Hodgkin and Huxley fitted curves399
to data showing the time course of the K+ conductance in order to obtain400
values of n∞ and τn, the same results can be obtained from macroscopic401
current traces without isolating the conductance; see reference [48].) αn and402
βn were then calculated at each voltage using equations (19) and (20), these403
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Figure 6: Steady state values (A) and time constants (B) of the Hodgkin-Huxley gating
variables as functions of v. Gates m and h are the Na+ channel activation and inactivation
gates, respectively. Gate n is the K+ channel gate
were plotted against voltage, and best fit functions were determined. These404
















where v is the deviation of the membrane potential V from rest (V = Vrest+v)407
in mV. It is these αn and βn rate coefficients that are used to calculate the408
voltage-dependent steady-state gating values [n∞; equation (24] and time409
constants [τn; equation (25)] for the K
+ channel, as shown in Fig. 6.410
Examining the time course of the experimentally recorded Na+ conduc-411
tance in Fig. 5C (open circles), it is apparent that two processes are working.412
The first is responsible for the increase in conductance, the second causing413
the conductance to decrease. Thus, during a voltage clamp to a new mem-414
brane potential, the current first activates and then inactivates, all at the415
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same membrane potential. To model this, Hodgkin and Huxley proposed416
that the Na+ conductance takes the form417
gNa = ḡNam
3h , (29)
where ḡNa is the maximal Na
+ conductance, m is the Na+ activation gating418
variable, and h the Na+ inactivation gating variable. Both gating variables419
are modelled using the differential equation (15), as for the K+ current gating420
variable n, and functions for αm, βm, αh and βh determined in a similar way421
































The resultant Na+ channel voltage-dependent steady-state activation and426
inactivation gating values (m∞ and h∞, respectively) and their associated427
time constants (τm and τm) are shown in Fig. 6.428
The descriptions of the time- and voltage-dependence for both the Na+429
and K+ conductances – equations (29) and (21) – can now be substituted430
into equation (9) to complete the model.431
2.4.1. The Hodgkin-Huxley model of the action potential in the squid giant432
axon433
In the previous section it was shown how Hodgkin and Huxley quantita-434
tively described the dynamics of the gates m, h and n that determine the435
time course of V during an action potential. Here it will be shown how these436
dynamics interact to result in the action potential. Note that Hodgkin and437
Huxley used the term v to denote the deviation of V from its resting level,438
where negative v denotes depolarisation. In this section, v = V −Vrest will be439
used such that depolarisation is denoted by positive v, which is perhaps more440










































Figure 7: Time course of the Hodgkin-Huxley model gating variables (A) and conductances
(B) underlying the action potential (C), in response to a 0.1 ms, −70 µA/µF stimulus
current applied at t = 0 ms
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When the cell is at rest (v = 0 mV) the K+ conductance gating variables442
n4 are dominant over the Na+ conductance gating variables m3h (see Fig.443
6A) and so v tends towards the reversal potential for K+, vK = −12 mV. If a444
small current is applied to the cell, a small depolarisation occurs but v returns445
to the equilibrium resting value v = 0 mV. However, if the stimulus current446
is large enough to take v past a threshold then m, which is approaching447
m∞ with a small time constant (see Fig. 6B) such that the process is fast,448
causes an increase in Na+ conductance, an increase in the inward Na+ current449
and a further, regenerative depolarisation. (For a qualitative phase space450
analysis of this threshold phenomenon, see reference [49].) Now the Na+451
conductance dominates over the K+ conductance and v tends towards vNa =452
115 mV. The gates h and n have also been moving towards their new voltage-453
dependent values h∞ and n∞, although with much slower time constants454
(Fig. 6B). Eventually, however, h takes on its new, low value, the Na+455
conductance falls and the Na+ current inactivates. At around the same456
time, K+ activation is increasing as n approaches its new, high value. K+457
conductance then increases and becomes dominant, the K+ current activates,458
and the membrane potential repolarises as v tends back towards vK. There459
is then a refractory period during which further stimuli will not cause an460
increase in Na+ conductance or, therefore, an action potential. This is due461
to the large time constant of the Na+ inactivation gate h (i.e. a slow process),462
which causes a relatively long delay in h moving to its resting, open value463
at v = 0 mV. The time course of the gating variables m, h and n and464
the conductances gNa and gK are shown in Fig. 7A,B in response to a supra-465
threshold stimulus. These changing conductances result in the depolarisation466
and subsequent repolarisation of the membrane – the action potential, which467
is shown in Fig. 7C.468
2.5. The FitzHugh-Nagumo Model469
The FitzHugh-Nagumo (FHN) model [50–53] is a caricature of the four-470
variable Hodgkin-Huxley model that is still used, sometimes in modified form471
[54, 55], as a computationally tractable excitation model for studying propa-472
gation in cardiac tissue. The model has two variables, and can be related to473
the Hodgkin-Huxley model by assuming that m is an instantaneous function474
of v, while h+ n is constant at 0.8 (see Figs. 6A and 7A). Therefore m as a475
state variable can be removed by setting m = m∞, and h as a state variable476
can be removed by setting h = 0.8 − n. The two remaining state variables,477
v and n, then become excitation and recovery variables, respectively. The478
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qualitative features of the Hodgkin-Huxley model are kept if the excitation479
and recovery variables in the FHN model – which are termed v and w, re-480
spectively – have similar dynamics (see Fig. 8 and compare to Fig. 7C).481
The only constraints on choosing functions for the FHN equations are that482
the nullcline of v is cubic, the nullcline of w monotonically increases and,483
for an excitable system, the choice of parameter values results in a stable484
steady state where the nullclines cross (see [49] for a description of FHN485
















= ǫ(v + β − γw) , (35)
where the parameters 0 < ǫ ≪ 1, 0 < γ and |β| <
√
3.488
2.6. Markovian Formulations of Ion Channels489
Markovian formulations for ion channels are used to model findings from490
molecular studies where an individual channel, away from its physiological491
cell environment, is found to exist in one of several specific states (e.g. closed,492
open, fast inactivated, slow inactivated). As such, Hodgkin-Huxley formal-493
ism, as represented by the simple schematic shown in Fig. 4, is unable to494
capture the more complicated dynamics exhibited by these channels. (Note495
that channels described by Hodgkin-Huxley formalism can be described using496
a simple Markovian formulation, but more complicated Markovian formula-497
tions cannot be represented using Hodgkin-Huxley formalism – see [56] for a498
detailed discussion.) Markovian formulations are particularly useful for mod-499
elling channelopathies due to genetic mutations or drug applications, where500
the ion channels are studied in isolated expression systems. A Markovian501
description of such experimental data combined with a cell or tissue model502
therefore enables the study of the effects of these single channel mutations503
on whole cell electrophysiology (e.g. [21, 57–62]).504
For a general Markov gating model where each of N states can potentially505
change to any other state, the probability of occupying a particular state, Pi,506







[kji · Pi(t, V )] +
N∑
j=1













for i = 1, 2...N − 1, i 6= j, and where kij is a voltage-dependent rate constant510
leading from state j to state i [63]. The rate constants, which are functions511
of membrane potential, are given by512
kij = exp(Aij +BijV + CijV
2) , (38)
where the parameters describe the potential energy barriers between the513
states: Aij represents the energy barrier height in the absence of an electrical514
field, Bij represents the energy barrier height that exists due to charge-field515
and dipole-field interactions and Cij represents the contribution of total dis-516
tortion polarisation or field induced dipoles [64]. In the limiting case of a517
low transmembrane field strength where the squared term is not required,518
equation (38) can be reduced to:519
kij = exp(Aij +BijV ) . (39)
However, Matsuoka et al. [65] found that high membrane potentials produced520
large rate constants that interfered with integration of cellular equations.521
An alternative, four parameter format that included saturation of the rate522
constants was therefore proposed:523
kij =
1
Aij exp(V/Bij) + Cij exp(V/Dij)
. (40)
Thus for a simple three-state chain Markov model of a single channel where524









and from equations (36) and (37), the equations to this model are:527
dPC
dt














Substituting equations (41) and (42) into equation (43) and simplifying gives:530
dPI
dt
= −kOIPI + kIOPO . (44)
In this situation there are four independent voltage-dependent rate constants531
(kCO, kOC , kOI and kIO) each having four parameters if equation (40) is532
used to define the rate constants, giving a total of 16 parameters (methods533
for obtaining these parameter values are discussed in [56, 66]). A typical534
equation for an ionic current will then take the form535
Iion = ḡPO(V − Erev) , (45)
so that the Hodgkin-Huxley-type gating variables are replaced with a single536
open probability, PO, describing the conductance of the channel.537
2.7. Development of Cardiac Cell Models538
Although the Hodgkin-Huxley model provided a formalism for modelling539
the action potential and the FitzHugh-Nagumo model is useful for study-540
ing phenomena associated with propagation where the spatio-temporal be-541
haviour of the wave of excitation is more important than the shape of the542
action potential, at a biophysical level they are models of neuronal action543
potentials and do not quantitatively reproduce the cardiac action potential544
due to their lack of ion channels specific to cardiac cells. Therefore a series545
of cardiac models have been developed to study problems specific to cardiac546
cells and tissue.547
The development of the current generation of biophysically detailed ven-548
tricular cell models can be traced back to the Hodgkin-Huxley model, as it549
provided a formalism for modelling the action potential. The model of No-550
ble [68, 69] for the Purkinje fibre was an adaptation of the Hodgkin-Huxley551
equations, and was the first biophysical model specifically for a cardiac cell.552
Cell models continued to be updated as the ionic basis of the cardiac ac-553
tion potential was determined experimentally. The discoveries of the cardiac554
Ca2+ current [70] and various components of what until then was considered555
as a single K+ current [71, 72] were followed in the 1970s by the McAllister-556
Tsien-Noble model [73], again for the Purkinje fibre, and the first model of a557
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Figure 8: Time course of the FitzHugh-Nagumo excitation variable v (i.e. the action
potential) and recovery variable w in response to a supra-threshold stimulus











Figure 9: (A) Schematic of the O’Hara-Rudy human ventricular cell model, from [67].
(B) Periodic steady-state O’Hara-Rudy model action potentials at a basic cycle length of
1000 ms. Solid line, endocardial cell model; dashed line, midmyocardial cell model; dotted
line, epicardial cell model. Note the morphological differences – especially the action
potential duration – between these biophysically-detailed human cardiac cell models and
the Hodgkin-Huxley model action potential in Fig. 7C
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ventricular muscle cell, the Beeler-Reuter model [74]. The inclusion of ionic558
concentration changes along with the Na+-K+ ATPase and the Na+-Ca2+559
exchanger came with the publication of the DiFrancesco-Noble Purkinje fi-560
bre model [75], although the Ca2+ transient in the model was too large [10].561
Accurate modelling of the intracellular calcium transient was the main fo-562
cus of the Hilgemann-Noble model [76] that, while being a model for atrial563
cells, provided a basis for future models of ventricular calcium handling. In564
1991 came the first phase of the Luo-Rudy model [77] followed in 1994 by565
the second phase incorporating dynamic concentration changes [27, 78]. The566
general outline of the Luo-Rudy model can be seen as a basis for many of to-567
day’s biophysically detailed cell models which as a matter of course contain568
various membrane currents (including those activated only during patho-569
logical conditions), dynamic ion concentrations and various levels of Ca2+570
handling, along with β-adrenergic control of E-C coupling (e.g. [79]) and dif-571
ferent metabolic pathways (e.g. [80]). In recent years, data describing ionic572
currents and action potentials in human ventricular cells and tissues have573
become available, and this has allowed the development and validation of574
models describing human ventricular electrophysiology [67, 81–83] (see Fig.575
9) that are perhaps more relevant than models of animal electrophysiology576
(especially rodents) in terms of clinical translatability.577
The increased complexity in these models has been paralleled by an in-578
crease in computing power that allows large-scale temporal and spatial prob-579
lems to remain tractable despite the increased levels of physiological detail;580
the current generation of biophysically detailed models typically include over581
20 state variables for voltage, gating, ionic concentrations etc., each with582
a differential equation to solve, as well as numerous other variables mod-583
elled using upwards of 100 algebraic equations. A more detailed review of584
the development of biophysically detailed cardiac cell models highlighting585
the iterative interaction between modelling and experimentation is given in586
references [5, 10, 84].587
2.8. Modelling Calcium Handling588
Influx of Ca2+ through the L-type Ca2+ channels results in a large re-589
lease of Ca2+ from the sarcoplasmic reticulum (an intracellular Ca2+ store),590
termed Ca2+-induced Ca2+ release (CICR), and a transient rise of intracellu-591
lar Ca2+ concentration (the “Ca2+ transient”). This Ca2+ transient not only592
causes contraction of the cell through binding of Ca2+ to troponin and the593
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subsequent interaction of actin and myosin filaments, but modulates mem-594
brane activity (e.g. via the Na+-Ca2+ exchanger) and can, under certain595
conditions, be arrhythmogenic (e.g. [20]). Accurate modelling of intracellu-596
lar Ca2+ handling is therefore necessary if an electrophysiology model is to be597
used to examine electrophysiological consequences of pathological conditions598
associated with Ca2+ overload and abnormal Ca2+ handling. A detailed de-599
scription of modelling of Ca2+ handling in cardiac cells is presented in Part600
1 of this two-part article (Colman et al., in this issue), while a historical ex-601
amination of the interaction between experiment and modelling with regards602
to Ca2+ handling can be found in [85–88].603
2.9. Methods of Integration604
2.9.1. The forward Euler method605
Although the ordinary differential equations used to describe the action606
potential in biophysically detailed excitation models are high order (i.e. many607
variables) and stiff (variables change with different time scales), they can be608
solved by simple finite difference methods. Typically, differential equations609
for membrane potential, e.g. those of the form of equation (6), and ionic con-610
centrations are solved using a simple forward Euler method. If we represent611
such an equation by612
dx
dt
= f(x) , (46)
then by integrating we wish to find the solution x(t), subject to the condition613
that x = x0 at time t = t0. The forward Euler method assumes that over614
a sufficiently small time step ∆t, the function f(x) remains constant and so615
the change in x during the time step can be approximated by f(x0)∆t. The616
new value of x at t0 +∆t, which we shall call x1, is therefore given as617
x1 = x0 + f(x0)∆t . (47)
The variable x is now at x1, the function f(x0) becomes f(x1), and t becomes618
t0 + ∆t. The next iteration will give us x2 = x1 + f(x1)∆t and take us to619
t = t1 +∆t, and so on. The general scheme is given by620
xn+1 = xn + f(xn)∆t , (48)
and is the simplest possible method of numerical integration, although one621
that is prone to errors in the calculated solution if the time step ∆t is not suf-622
ficiently small. For increased numerical accuracy, an integration scheme such623
as the fourth order Runge-Kutta method may be employed [89], although this624
will increase computation time with respect to the Euler method.625
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2.9.2. Integrating equations for gating variables626
Integration of the equations describing gating variables with Hodgkin-627
Huxley formalism is carried out using the scheme of Rush and Larsen [90],628
who showed that the solution to the general gating equation629
dk
dt
= αk(V )(1− k)− βk(V )k . (49)
could be given by630
k = k∞(V )− (k∞(V )− k0) exp(−∆t/τk(V )) , (50)
where ∆t replaces t from the exact solution as in equation (16) if it was631
assumed that the α and β rate coefficients that define k∞ and τk – equations632
(17) and (18) – remained constant over the sufficiently small time step ∆t.633
For the subsequent iteration, k becomes k0. This is known as the Rush-634
Larsen scheme, and is more accurate than integrating equation (49) with the635
forward Euler method as the solution to equation (50) is dependent only on636
the membrane potential V rather than the derivative of k.637
2.9.3. Variable time steps638
As the choice of ∆t determines, to a large extent, the speed of integra-639
tion, then it is desirable to have as large a time step as possible without640
reducing accuracy of the solutions, particularly during simulations with long641
pacing runs or when searching parameter space. When the solutions to the642
differential equations are changing slowly then a large time step may be used643
without compromising accuracy. As dV/dt is the variable that changes most644
rapidly in the majority of models, a variable time step dependent on dV/dt645
can be used such that ∆t is large when dV/dt is small, and vice versa. Thus,646
during the upstroke of the action potential, ∆t will be small, but during647
the plateau and at resting membrane potentials, ∆t can be large, allowing648
for faster integration. One relatively simple scheme for a variable time step649
that is used to integrate the Hund-Rudy equations describing canine ventric-650
ular electrophysiology [29] has the following conditions: if dV/dt exceeds 1651
mV/ms, up to 5 ms after dV/dt exceeds this threshold, or within 2 ms before652
or after a stimulus current is applied, a minimum time step of ∆t = 0.005 ms653
is used; between 5 and 20 ms after dV/dt exceeds the 1 mV/ms threshold, a654
medium time step of ∆t = 0.01 ms is used; at all other times a time step of655
∆t = 0.1 ms is used. Therefore, a small time step is used when the membrane656
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potential will be changing rapidly, i.e. phase 0 depolarisation, with larger657
time steps used at other times, and the time taken to integrate the equations658
is considerably reduced.659
2.9.4. Tabulating exponential functions660
One major computational demand is solving the exponential functions661
in the equations describing cell electrophysiology, as the program must call662
libraries of functions to solve the exponentials, a time-consuming process, es-663
pecially with tissue-level simulations. As most of these exponential functions664
are explicitly voltage-dependent, it is possible to pre-calculate their values at665
certain voltages, and store these values in a lookup table that can be referred666
to by the program when needed. For cardiac excitation models, voltage-667
dependent exponential functions can be calculated for every voltage between668
−100 and +100 mV in 0.1 mV steps. Typically, there are around 40 such669
exponential equations in a cell model, and so a 40 × 2001 array is needed670
to store the pre-calculated function values. (Note that these lookup tables671
need to be expanded when simulating the effects of shocks on tissue, where672
voltage may go out of physiological ranges [91].) To further speed up com-673
putation time, the process could be extended to include other exponential674
or logarithmic functions such as reversal potentials and equations describing675
calcium handling.676
3. Modelling Propagation in Ventricular Tissue677
In an excitable medium such as cardiac tissue, cellular excitation prop-678
agates as waves of excitation. During normal sinus rhythm, the wave of679
excitation begins at the sinoatrial node, then propagates through the atria680
and the atrioventricular node, before moving down the His-Purkinje con-681
ducting system and exciting the endocardial surfaces of the ventricles. This682
is essentially a one-dimensional sequence, although propagation through the683
thin-walled atria may be considered as two-dimensional, and can be mod-684
elled as propagation in a two-dimensional sheet of tissue. The ventricles,685
however, are three-dimensional structures, with transmural and base-apical686
heterogeneities that affect both local excitation (e.g. membrane current den-687
sities and kinetics, and calcium handling) and the propagation of excitation688
(e.g. due to the influence of myocyte orientations and sheet structure), and689
so the modelling of propagation of excitation through the ventricles should be690




Figure 10: Schematic of a linear one-dimensional cable. Im denotes the membrane current,
Ia the axial current and d the diameter of the cable
useful for examining phenomena related to, for example, re-entrant arrhyth-692
mias, such as conduction velocity restitution (in 1D) and wavefront curvature693
(in 2D) [5].694
If the coupling between cells is strong, as in the ventricles, then the ul-695
trastructure of the tissue (cell membranes, connexins and gap junctions etc.)696
can be neglected and the tissue can be thought of as a continuous medium697
[92]. Such a continuous medium can be described using partial differential698
equations (PDEs), and so the tissue model in this case will be continuous699
state, continuous space and continuous time. Local membrane excitability700
in these PDE models can be described either by simple models such as the701
FitzHugh-Nagumo excitation equations [50–53] or their derivatives [54, 55]702
(see section 2.5), or by using biophysically detailed models such as those de-703
scribed in section 2.7. The propagation of excitation throughout the medium704
is then described using non-linear cable theory [93].705
3.1. Propagation in One Dimension: Non-Linear Cable Theory706
Propagation throughout ventricular tissue can be modelled using non-707
linear cable theory, extended from one spatial dimension to two or three as708
appropriate. Here, propagation along a simple cylindrical cable is considered709
– non-linear cable theory. Linear cable theory is discussed in detail in Jack et710
al. [93], with the non-linear excitation equations discussed earlier in Section711
2 leading to a need to extend the theory to include non-linearities. Regardless712
of whether linear or non-linear, the derivation of the axial component of the713
cable equation is the same.714
Figure 10 shows a schematic of a linear one-dimensional cable where the715
extracellular resistance is neglected such that the model is described as mon-716
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odomain. The membrane current Im is modelled with capacitive and ionic717
components as described in Section 2. The intracellular fluid resistance is718
represented by an ohmic resistance so that, in the case where membrane con-719
ductance is zero and so no current flows across the membrane, the relation720




= −raIa , (51)
where x is the distance along the cable, and ra is the intracellular resistance723
to axial flow of current per unit length of cable, given by Ri/πd
2 where Ri is724
the specific intracellular resistivity and d the diameter of the cable. Here it725
is assumed that the membrane conductance, and so the membrane current726
Im, along the length ∆x is zero. In the one-dimensional cable, larger values727
of V at smaller values of x (i.e. a negative ∆V/∆x) should give rise to a728
positive axial current, i.e. the current flows down a potential gradient; the729
negative sign in equation (51) imposes this condition.730
Membrane conductance, however, is rarely negligible, even at steady state731
due to the presence of leakage currents. It is therefore necessary to consider732
the differential form of equation (51) where ∆x is given by the limit ∂x, and733
∂V is the voltage difference:734
∂V
∂x
= −raIa , (52)
where ∂V/∂x and Ia are measured at the same point along the cable. As735
any change in the axial current Ia should come from flow of the membrane736
current Im, then from Kirchhoff’s current law the membrane current must737
be equal and opposite to the change in axial current across that point738
∂Ia
∂x
= −Im . (53)
If we assume that ra remains constant along the length of the cable and739







we can then substitute equation (53) into equation (54) to obtain741
∂2V
∂x2
= raIm , (55)
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It has already been shown in section 2.3 that Im is composed of a capacitive743




+ Iion . (57)
We now have two differential equations for the membrane current, one differ-745
entiated twice with respect to space, the other differentiated with respect to746
time. By combining these two equations, (56) and (57), we obtain the basic747








+ Iion . (58)
As Iion is related to V in a non-linear fashion, the equation cannot be solved749
analytically and so solutions must be obtained by numerical integration. Jack750
et al. [93] discuss the situation where Iion has a linear relation with V and751
so can be solved analytically. By rearranging equation (58) and substituting752










we have a version of the non-linear cable equation which is a parabolic partial755
differential equation of the reaction-diffusion type, the component (1/Cm)Iion756
being the membrane reaction and the componentD(∂2V/∂x2) the diffusion of757
voltage along the cable. Equation (59) assumes that the diffusion coefficient758
D is constant throughout the medium. However, if D changes spatially,759
as is the case when fibre orientation is included in the model geometry or760
when including regions of ischaemic tissue, for example, we must take into761














It is sometimes more convenient to write equations (59) and (60) in the forms763
∂V
∂t





Figure 11: Re-entrant spiral wave solution in a 12 cm square homogeneous, isotropic two-
dimensional virtual tissue, with excitation described using the epicardial ten Tusscher-




= ∇(D∇V )− Iion , (62)
respectively. Here ∆ = ∇2 = ∂2/∂x2 is the Laplace operator, and ∇ =765
∂/∂x is the spatial gradient operator, both in one spatial dimension for this766
example. The term 1/Cm is omitted here as Cm = 1 µF.cm
−2 in most767
ventricular models.768
3.2. Propagation in Two and Three Dimensions769
Simulated propagation of excitation in two- and three-dimensional media770
allows a variety of wave phenomena to be studied, including, for example, re-771
entrant waves (e.g. [82]; see Fig. 11) and the effects of wavefront curvature772
[94]. The effects of myocyte orientations can be included in such models,773
an important consideration as propagation occurs faster along the myocyte774
than across it [95]. The equations used to model propagation in two- and775
three-dimensional media are extensions of the one-dimensional non-linear776
cable equation, extended to two and three dimensions and with the effects777
of myocyte orientation (and therefore anisotropy of diffusion) included.778
There are three principal axes of diffusion throughout ventricular tissue779
– the myocyte direction (historically called the “fibre” direction), the sheet780
plane and the sheet normal [96]. Orthotropic propagation (i.e. different dif-781






Figure 12: Snapshots of propagating wavefronts from a central spherical source in homo-
geneous 2 cm cubes of ten Tusscher-Noble-Noble-Panfilov endocardial human tissue [81].
(A) A spherical wavefront is obtained in isotropic tissue (A). In anisotropic tissue the
wavefront is a prolate ellipsoid (B), while in orthotropic tissue it is a scalene ellipsoid (C)
be modelled in three dimensions, results in different wavefront geometries783
compared to isotropic or anisotropic propagation. The effects of introduc-784
ing anisotropy and orthotropy of diffusion on the geometry of a propagating785
wavefront are illustrated in Fig. 12. The cubes are 2 cm slabs of endocar-786
dial ten Tusscher-Noble-Noble-Panfilov model [81] tissue with homogeneous787
myocyte orientations, with the Cartesian axes f, s, and n corresponding to788
the myocyte, sheet, and sheet normal directions, respectively. If diffusion789
is isotropic then diffusion and conduction velocity are identical in all direc-790
tions and the shape of the propagating wavefront is spherical (Fig. 12A).791
If anisotropy of diffusion is introduced then propagation is fastest in the792
myocyte direction (f), but is equal in the sheet (s) and sheet normal (n)793
directions; thus the wavefront geometry is prolate ellipsoidal with the polar794
axis in the f direction (Fig. 12B). Reducing the diffusion coefficient in the795
sheet normal direction introduces orthotropy of diffusion; propagation is then796
different along the three principal axes, being fastest along the myocyte (f)797
and slowest in the sheet normal (n) direction, to give a wavefront geometry798
that is scalene ellipsoidal (Fig. 12C).799
Because of these differences from one-dimensional propagation, and for800
completeness, the equations for three-dimensional propagation are presented801
here in full. To model two-dimensional media, the same equations can be802
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used but with any reference to the z or n directions removed (for example,803
in a two-dimensional medium the electrical diffusion tensor D in equation 65804
will become a 2× 2 tensor with four terms: Dxx, Dxy, Dyx and Dyy).805
3.2.1. Reaction-diffusion equation in three dimensions806
In three dimensions the reaction-diffusion equation is807
∂V
∂t
= ∇(D∇V )− Iion , (63)



















Equation (63) can be written as a sum of doubly repeated indices [97] where810














− Iion . (66)
The sum in three dimensions will have nine terms, as there are nine possible812
pair combinations of x, y and z. The sum in two dimensions will only have813
four terms as there are four possible pair combinations of x and y: (x, x),814
(x, y), (y, x) and (y, y).815
3.2.2. Calculating the electrical diffusion tensor816
Diffusion throughout the 3D heart (or a 2D sheet), and therefore the817
diffusion tensor D, are functions of space and are determined by the tissue818
myocyte and sheet structure at any given point. The directions f , s and n can819
be determined experimentally using histological methods, as for the Auckland820
canine cardiac geometry [98–100] and the San Diego rabbit cardiac geometry821
[101], or using diffusion tensor magnetic resonance imaging [18, 102, 103]822
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(see section 4.1). In a local coordinate system based on these vectors, the823









where D‖ is electrical diffusion along the myocyte axis, D⊥1 is diffusion in the825
sheet plane perpendicular to the fibre axis, and D⊥2 is diffusion normal to the826
sheet plane (i.e. in the directions f , s and n, respectively). In order to find827
the components of the diffusion tensor D in the global Cartesian coordinate828
system, we must transform D̃ which uses a local coordinate system. As the829
three directions f , s and n are the eigenvectors of the diffusion tensor D with830
corresponding eigenvalues D‖, D⊥1 and D⊥2, then from linear algebra [97]831
the transformation matrix of D̃ to D is an orthogonal matrix832
























and where the subscripts x, y and z denote the components of the corre-834
sponding vectors with respect to the global Cartesian coordinate system. In835
this global Cartesian coordinate system the diffusion tensor D is then836
D = AD̃AT , (70)
where the superscript T denotes matrix transpose. The matrices A and AT837
are the transformation matrices from the local to global coordinate systems838






If it is assumed that diffusion perpendicular to the myocyte axis is the same in841
all directions (i.e. D⊥1 = D⊥2) then equation (71) can be simplified [97, 104]842
using the fact that A is an orthogonal matrix such that843











is the identity matrix. Substituting equation (72) into equation (71) then845
gives a representation of the electrical diffusion tensor D in terms of the846
vector describing myocyte axis orientation, f , and the diffusion coefficients847
D‖ and D⊥1:848
D = D⊥1I+ (D‖ −D⊥1)ffT . (74)
Therefore, for modelling anisotropic propagation where diffusion is the same849
in the sheet plane and across the sheet plane, the diffusion tensor can be850
calculated using equation (74). However, for modelling orthotropic propaga-851
tion, where diffusion in the sheet plane and across the sheet plane is different,852
the diffusion tensor must be calculated using equation (71).853
3.2.3. Calculating the diffusion term854
The sum of the diffusion terms in equation (66) can now be calculated.855














































Equation (66) can therefore be conveniently written as858
∂V
∂t
= S1 + S2 − Iion , (77)
giving two sum terms, S1 and S2, that can be treated individually. For the859



























































For the second sum term, S2, we expand as follows, bearing in mind that the863


































3.2.4. Discretisation scheme in three dimensions867
We can now discretise the three dimensional reaction-diffusion equation868
(66) by taking discrete time steps ∆t such that t at time step k is given by869
tk = t0 + k∆t k = 0, 1, 2, . . . , K , (80)
and discrete space steps ∆x = ∆y = ∆z = h such that the point in space870
(x, y, z) at space step (l,m, n) is given by871
xl = x0 + l · h l = 0, 1, 2, . . . , L , (81)
872
ym = y0 +m · h m = 0, 1, 2, . . . ,M , (82)
873
zn = z0 + n · h n = 0, 1, 2, . . . , N . (83)
The time derivative on the left-hand side of equation (66) is discretised using874
the Euler method as in equation (48). The derivatives in S1 and S2 (equations875
(78) and (79)) are approximated using central difference methods and values876
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Using equations (48) and (84)-(101), the three dimensional reaction-diffusion895
equation (66) can be discretised and rearranged to give a solution for V at896
time step k + 1.897
3.3. Boundary conditions898
Boundary conditions determine what happens to a variable of interest899
at the edge of a geometry, and generally take one of two forms in cardiac900
models: Euler or Neumann. For a one-dimensional cable, Euler (or cut-end)901
boundary conditions represent the cut end of a fibre where the potential is902
abolished, such that903
V |x=0,L = 0 , (102)
and so in a discretisation scheme is simply implemented by setting V = 0 mV904
at x = 0 and x = L (i.e. at each end of the fibre). Alternatively, Neumann905
(or no-flux) boundary conditions represent the experimental situation where906
the ends of a cut fibre or the edges of an extracted slice or slab of tissue seal907
over within a minute [105], or the physiologic boundaries of an in vivo or908
ex vivo tissue or organ, the entire ventricles for example. A such, Neumann909
boundary conditions are the appropriate choice for modelling cardiac tissue910
in the majority of situations. In a 1D model, Neumann boundary condi-911






= 0 . (103)
In a discretisation scheme for a 1D model, Neumann boundary conditions914
are implemented using915
V k+10 = V
k+1
1 ,









= 0 , (105)
where v is the exterior normal to the boundary ∂Ω of the two-dimensional917
medium R2 or three-dimensional medium R3, and where ∂Ω ⊂ R2 in 2D and918
















= 0 , (106)
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which in the discretisation scheme is implemented using921






(L−1,m,n) for all m,n ,






(l,M−1,n) for all l, n ,






(l,m,N−1) for all l,m .
(107)
For irregular geometries such as whole ventricles or ventricular wedges, how-922
ever, the implementation of boundary conditions is not so straightforward.923
The process involves finding the surface-normal vector for each node lying on924
the surface of the geometry. By assuming that the entire heart tissue is isopo-925
tential and at a different potential from outside the tissue, the fact that the926
current flow in an isotropic medium is normal to equipotential surfaces can927
be used to determine these surface normals [97, 106]. The node on the surface928
of (but inside) the tissue is then paired with its nearest-neighbour node lying929
outside the tissue and closest to the surface normal. Both are then assigned930
the same voltage, given for the node in the tissue by the reaction-diffusion931
PDE. An alternative algorithm based on the phase-field method, rather than932
calculating the surface normal, has also been suggested [107, 108].933
3.4. Stability of the discretisation scheme934
An important consideration when determining a differencing scheme for935
the reaction-diffusion PDE, in addition to the computational efficiency of the936
discretisation method, is the stability of the chosen method. von Neumann937
linear stability analysis [89] places constraints on the choice of ∆t and ∆x so938







where d is the number of spatial dimensions. However, due to the stiff, non-940
linear nature of the reaction-diffusion PDE and the biophysically detailed941
equations used to determine Iion, this stability criterion is sometimes not942
sufficient; in such cases, the stability of the discretisation scheme can be943
checked by comparing the convergence of the solutions under variations of944
∆t and ∆x.945
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3.5. Additional Methods for Integrating PDEs946
The discretisation schemes presented in this chapter so far have all been947
Forward Time Centred Space explicit methods that, while being the sim-948
plest methods available and in terms of computational load are relatively949
undemanding, produce accurate numerical solutions. However, when work-950
ing with biophysically detailed excitation equations that can have more than951
20 differential equations and upwards of 100 algebraic equations to solve,952
and large geometries such as the whole ventricles that contain upwards of953
106 nodes, it becomes necessary to utilise additional methods of integration954
in order to reduce computation time. In addition to the tabulation of ex-955
ponential functions as described in section 2.9.4, the following methods may956
decrease computation time and increase tractability of computational simu-957
lations.958
3.5.1. Operator splitting and adaptive time steps959
As discussed in section 2.9.3, the integration time of single cardiac cell960
ODEs could be significantly reduced by applying an adaptive time step al-961
gorithm, where a small time step was used when the membrane potential962
was changing rapidly (e.g. during the phase 0 action potential upstroke)963
while a larger time step could be utilised when the membrane potential was964
changing more slowly. While applying such an adaptive time step algorithm965
would obviously be advantageous when solving the equations for simulations966
where total integration time is long-term and/or where large-scale geome-967
tries are being used, its direct application to the reaction-diffusion PDE is968
not straightforward. The problem of applying an adaptive time step algo-969
rithm arises because the diffusion component of the PDE must be calculated970
when all nodes in the tissue are at the same point in time. Using a large time971
step in a part of the tissue where the membrane potential is changing slowly972
will result in that part of the tissue moving forwards in time at a greater rate973
than a part of the tissue where a smaller time step is being utilised, and a974
disturbance to the synchronisation of time arises between nodes throughout975
the tissue. However, the technique of operator splitting [89] can be applied to976
the reaction-diffusion PDE to separate the reaction and the diffusion com-977
ponents, which can then be solved separately, with an adaptive time step978
algorithm being applied to the reaction component. This technique has been979
verified for the one- and two-dimensional cardiac reaction-diffusion PDE by980
Qu & Garfinkel [109], and will be described here using their method. The981
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reaction-diffusion PDE in one-, two- or three-dimensional cardiac tissue is982
∂V
∂t
= ∇(D∇V )− Iion , (109)
where ∇ is the spatial gradient operator in one, two or three dimensions as983
appropriate. Now consider the analogous differential equation984
∂V
∂t
= (Γ1 + Γ2)V , (110)
where Γ1 and Γ2 are differential operators for the diffusion and the reaction985
components, respectively. Equation (110) can be integrated approximately986
as987
V (t+∆T ) = e(Γ1+Γ2)∆TV (t) , (111)
where we use ∆T to denote a maximum time step for reasons described988
later. Using the operator splitting method [89] this equation can further be989
approximated as990
V (t+∆T ) = eΓ1∆T/2eΓ2∆T eΓ1∆T/2V (t) +O(∆T 3) . (112)
To apply this method to integrate equation (109) in the interval [t, t+∆T ],991
we proceed using 3 integration steps per maximum time step ∆T as follows.992
In step 1 we use initial conditions at time t to integrate equation (109) for a993
time step of ∆T/2 using only the diffusion component:994
∂V
∂t
= ∇(D∇V ) , for a time step ∆T/2 , (113)
which is equivalent to applying the differential operator eΓ1∆T/2 to V (t) in995
equation (112). For step 2, we use as initial conditions the conditions from996




= −Iion , for a time step ∆T , (114)
where the state variables (gating, ionic concentrations etc.) in the equations999
describing Iion are also updated. This is equivalent to applying the differential1000
operator eΓ2∆T to the term eΓ1∆T/2V (t) in equation (112). For step 3 we again1001
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integrate equation (109) for a time step of ∆T/2 using only the diffusion1002
component, this time using the results of step 2 as initial conditions:1003
∂V
∂t
= ∇(D∇V ) , for a time step ∆T/2 , (115)
which is equivalent to applying the differential operator eΓ1∆T/2 to the eΓ2∆T eΓ1∆T/2V (t)1004
term in equation (112). This step completes the integration of equation (109)1005
in the interval [t, t+∆T ], and t then takes on the value t+∆T before the three1006
steps are repeated over the next time step ∆T . The advantage of using this1007
operator splitting method is that we can now apply an adaptive time step al-1008
gorithm during step 2, as there is no diffusion component to solve during this1009
step and so, as long as all nodes are integrated for a total time ∆T , the time1010
synchrony between nodes during the step is irrelevant. As the majority of1011
computations (i.e. the stiff, high-order membrane excitation equations) are1012
carried out during step 2, the application of an adaptive time step algorithm1013
here dramatically decreases computation time. A minimum time step ∆tmin1014
must be chosen so that ∆T/∆tmin is an integer in order to keep all nodes1015
synchronised at the end of step 2, and so that integration of the equations1016
describing Iion is accurate. The maximum time step ∆T is chosen bearing in1017
mind numerical stability of the integration, and is generally checked for by1018
comparing convergence of solutions under variation of ∆T . The actual time1019
step used during step 2, ∆t, is then some integer multiple of ∆tmin up to a1020
maximum of ∆t = ∆T . Qu & Garfinkel [109] suggested an adaptive time1021
step algorithm where ∆tmin = 0.01 ms and ∆T was set up to 0.4 ms for one-1022
dimensional simulations and up to 0.3 ms for two-dimensional simulations.1023
∆t was then determined according to ∆t = ∆T/k where k = k0+int(|∂V/∂t|)1024
and where k0 = 5 if ∂V/∂t > 0 else k0 = 1, in order to set up a protective1025
zone to maintain safe propagation of any excitation wavefront. Finally, if1026
k > ∆T/∆tmin then k = ∆T/∆tmin. However, any adaptive time step algo-1027
rithm that integrates the cellular membrane excitation equations accurately1028
can be utilised.1029
3.5.2. Parallelisation under openMP and MPI1030
Because of the large spatial and temporal scales of cardiac simulations,1031
and the limitations in terms of the computing power of single processors, it is1032
necessary that computer codes are parallelised to run on multiple processors.1033
Each processor then generally handles the equations needed to solve excita-1034
tion and propagation in a specific subsection of the geometry, with communi-1035
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cation between processors necessary for calculating the diffusion terms at the1036
boundaries of each smaller geometry. Two of the most important standards1037
for parallelisation of computer codes are openMP (open multi processing)1038
and MPI (message passing interface).1039
openMP is a specification for parallelising codes for shared memory ma-1040
chines (where there are multiple processors but a single memory shared be-1041
tween all these processors) and takes the form of a set of compiler directives,1042
library routines and environment variables for use with the C, C++ and1043
Fortran computer programming languages. One advantage of using openMP1044
is that the serial source code (e.g. a three-dimensional model) need not be1045
considerably altered, and requires the placement in the code of directives1046
that parallelise some form of looping construct such as a for loop.1047
MPI is an interface standard for parallelising codes for machines with a1048
distributed memory architecture (where there are multiple processors each1049
with its own memory). With these architectures it is necessary for processors1050
to send and receive messages to and from other processors when determining1051
the diffusion terms at the boundaries of their own local geometries. Imple-1052
menting MPI requires that the source code be adapted to the specific needs1053
of MPI, e.g. the programmer has to specifically define when messages will be1054
sent and received, and is therefore not as straightforward as implementing1055
openMP.1056
The exact implementation of openMP or MPI is dependent on the code1057
being parallelised, and so a detailed description of the parallelisation of spe-1058
cific cardiac model codes is not given here other than to say that, in gen-1059
eral, any construct such as a for statement that loops through the car-1060
diac geometry can be parallelised. For more information on openMP and1061
MPI see references [110, 111] or online at http://www.openmp.org/ and1062
http://www.mpi-forum.org/.1063
3.5.3. Parallelising irregular geometries1064
Parallelisation is usually undertaken by assigning a regular subsection of1065
the total geometric area (e.g. a number of slices) to individual processors.1066
If the tissue geometry is irregular, such as the whole ventricles, this regular1067
assigning of space to processors may result in one processor solving equations1068
for more tissue nodes than another processor – consider, for example, one1069
processor handling the nodes in several apical slices of the geometry where1070
relatively few nodes are inside the tissue, versus another processor handling1071
nodes in the same number of basal slices where there are more nodes lying1072
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in the tissue. This will reduce computation time as the processor with fewer1073
tissue nodes waits for the other processors to calculate to the end of the time1074
step (with parallelisation, each processor must be synchronised in time when1075
the diffusion term of the reaction-diffusion PDE is calculated). In order1076
to solve this problem, linear N element arrays containing the x, y and z1077
locations of all nodes lying in the tissue can be created, with the elements of1078
the arrays labelled 0 . . . N − 1, where N is the total number of nodes in the1079
tissue. Each processor is then assigned an equal number of these N nodes1080
to solve equations for, with the x, y and z locations from the linear arrays1081
allowing reference to the state variables for each node.1082
4. Experimental Data for Parameterising and Validating Tissue-1083
Level Cardiac Models1084
With a mathematical/computational framework in place to describe tissue-1085
level cardiac electrophysiology, experimental data are required to fulfil two1086
major purposes: parameterisation and validation. Parameterisation is the1087
process of assigning values or functions to model parameters such as ion1088
channel maximal conductances (ḡ) and kinetics (τ), and the components of1089
the electrical diffusion tensor D̃ (i.e. values for D‖, D⊥1 and D⊥2) [5, 112].1090
Validation is the process of checking that model outputs, such as action po-1091
tential duration and conduction velocity, are acceptable with respect to those1092
measured experimentally [24, 84, 113].1093
Experimental techniques used for parameterising and validating sub-cellular1094
models of calcium handling are discussed in Part 1 of this two-part article1095
(Colman et al., in this issue), while the use of ion channel and action po-1096
tential data in constructing cell-level electrophysiology models are discussed1097
in [112]. Here we briefly discuss two tissue-level imaging techniques used to1098
parameterise and validate ventricular models, namely ex vivo diffusion tensor1099
magnetic resonance imaging (DT-MRI) and optical imaging.1100
4.1. Diffusion Tensor Magnetic Resonance Imaging1101
Myocyte orientation and sheet structure throughout the ventricular my-1102
ocardium is responsible for many of the phenomena associated with the func-1103
tion of the heart, including spread of electrical excitation during both nor-1104
mal sinus rhythm and arrhythmias [95]. Propagation of electrical activity1105
is anisotropic, being fastest in the direction of the long axis of the myocyte1106
due to the presence of gap junctions that are principally located at the ends1107
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of the myocytes [114–116]. Where sheets are present, propagation is or-1108
thotropic, being slowest in the direction normal to the sheet plane [117].1109
The myocyte and sheet architecture throughout the ventricles could itself1110
be a substrate for arrhythmias including ventricular tachycardia and fibrilla-1111
tion, and sudden cardiac death, as has been suggested in both experimental1112
(e.g. [118–121]) and theoretical (e.g. [55, 122–124]) studies. Furthermore,1113
fibre orientation can change during certain pathological conditions such as1114
hypertrophy [125], ischaemic heart disease [126] and heart failure [124]. If1115
one wishes to study these phenomena, it is therefore important to include1116
accurate representations of the three-dimensional geometry (shape) and ar-1117
chitecture (myocyte/sheet structure) of the ventricles into tissue-level mod-1118
els.1119
Previous studies characterising the structure of the myocardium have1120
utilised histological techniques in order to determine both myocyte orienta-1121
tion [127–129] and sheet structure [96, 130], or polarised light microscopy1122
for determining myocyte orientation [131]. Myocyte orientation is known to1123
follow a transmural helical pattern such that the inclination of the myocytes1124
with respect to the short axis of the heart (the “inclination angle”, also re-1125
ferred to as the “helix angle”) shifts from positive at the endocardium to neg-1126
ative at the epicardium, changing sign at the midwall. The meticulous study1127
of LeGrice et al. [96] suggested an organisation of the myocytes at a higher1128
level into a laminar structure with sheets approximately four myocytes thick,1129
with these sheets separated by sheet cleavage planes. The cleavage planes1130
ran radially from the endocardium to the epicardium and, when viewed in1131
a long axis transmural plane, could be seen to shift from a base-apex di-1132
rection near the apex through to an apex-base direction in basal regions.1133
However, histological techniques, even if the tissue does not require fixing as1134
for polarised light microscopy, require reconstruction of myocyte and sheet1135
orientations from sections and therefore introduce problems of distortion and1136
alignment, and it is difficult to reconstruct the three-dimensional orientation1137
of a myocyte or sheet as only angles in the stack of cut planes can be directly1138
measured. Furthermore, most datasets describing geometry and architecture1139
obtained using histological methods – such as the Auckland canine model1140
[98–100] and the San Diego rabbit model [101] – are spatially smoothed; as1141
such, they may not allow one to study the role of abrupt changes in myocyte1142
orientation in arrhythmogenesis, for example.1143
Diffusion tensor magnetic resonance imaging (DT-MRI) [132] has been1144










Figure 13: (A) Schematic of cardiac myocytes arranged into a laminar sheet structure.
The arrows indicate how DT-MRI eigenvectors correspond to ventricular architecture.
Adapted from [100]. (B) Maps of “fibre helix angle” (the inclination of the local myocyte
axis with respect to the short axis of the heart) on a cut surface along the long axis of
a rat heart (the grey surface is the endocardium of the left ventricle), and in three short
axis slices taken from basal, equitorial and apical regions. From [18]
three-dimensions both the myocyte orientation and sheet structure through-1146
out the ventricles. (The technique was originally applied to trace fibre tracts1147
in the central nervous system [133–135], hence the common use of the term1148
“fibre orientation” in the literature when DT-MRI is applied to the heart,1149
even though “fibres” as such do not exist in the myocardium.) A detailed1150
description of the DT-MRI technique is beyond the scope of this article, but1151
interested readers are directed to reference [136]. Briefly, however, DT-MRI1152
measures the diffusion of the proton (1H) of water molecules (H2O) in at least1153
six different directions, at locations (voxels) throughout the sample of inter-1154
est [137]. These directional diffusion data are then used to construct a 3× 31155
proton diffusion tensor at each voxel, that describes the three-dimensional1156
diffusion of protons at that point in space. The eigenvectors and eigenvalues1157
of the tensor are then calculated: these three eigenvectors correspond to the1158
principal orthogonal directions of proton diffusion, with the associated eigen-1159
values quantifying the magnitude of the diffusion in those directions. The1160
three eigenvectors are ranked as primary, secondary or tertiary (v1, v2 or v3,1161
respectively) according to the magnitudes of their associated eigenvalues (λ1,1162
λ2 and λ3, respectively): the eigenvector with the largest eigenvalue is the1163
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primary eigenvector, v1, while the tertiary eigenvector, v3, is the eigenvector1164
with the smallest eigenvalue; the remaining eigenvector (with the intermedi-1165
ate eigenvalue) is the secondary eigenvector, v2.1166
Because cardiac myocytes have an elongated, rod-like shape [138], proton1167
diffusion is greatest along the axis of the myocyte. As such, the primary1168
eigenvector of the proton diffusion tensor corresponds to local myocyte ori-1169
entation [139–141]. Where myocytes are organised into sheet-like structures,1170
proton diffusion will be smallest normal to the sheet plane: therefore, as the1171
three diffusion tensor eigenvectors are orthogonal, the secondary eigenvector1172
corresponds to the direction perpendicular to the myocyte axis but lying in1173
the sheet plane, while the tertiary eigenvector is normal to the sheet plane.1174
As such, the secondary and tertiary eigenvectors give a measure of ventricular1175
sheet structure [142, 143] (see Fig. 13A). Eigenvector orientations can there-1176
fore be quantified to give maps of myocyte and sheet structure throughout1177
the myocardium (see Fig. 13B).1178
It follows from the above that the directions of the primary, secondary1179
and tertiary DT-MRI eigenvectors (v1, v2 and v3) correspond to the vectors1180
f , s and n, respectively, in equation (69), i.e. v1 = f , v2 = s and v3 = n.1181
Therefore, the DT-MRI eigenvectors can be used to calculate the electrical1182
diffusion tensor (equation 65) in the PDE describing propagation of elec-1183
trophysiological excitation (equation 63), through equation (70). However,1184
although the DT-MRI eigenvectors (i.e. the principal directions of proton1185
diffusion) relate to the vectors f , s and n (i.e. the principal directions of1186
local myocyte orientation), we are not aware of any data suggesting that the1187
DT-MRI eigenvalues (i.e. the magnitudes of proton diffusion) relate to the1188
parameters D‖, D⊥1 and D⊥2 (i.e. the magnitudes of electrical diffusion).1189
We therefore need additional experimental data to allow us to completely1190
parameterise the electrical diffusion tensor D in equation (65).1191
4.2. Optical Imaging1192
Optical imaging (also known as optical mapping) of the heart can provide1193
data to parameterise and partially validate cardiac tissue models. The ap-1194
plication of voltage sensitive dyes to isolated and perfused cardiac tissue and1195
hearts (using the Langendorff technique) allows the visualisation of spatio-1196
temporal electrical activity, and has allowed the quantitative study of normal1197
sinus rhythm and the organisation and development of cardiac arrhythmias1198





Figure 14: Optical imaging data used to parameterise and validate tissue-level cardiac
electrophysiology models. (A) Colour-coded activation times across the right ventricular
epicardial surface of an isolated perfused rat heart. (B) Optical imaging-derived con-
duction velocity restitution from healthy and diseased rat hearts: CON, control; HYP,
hypertrophic; FAIL, failing. (C) Simultaneous optical imaging measurements of changes
in membrane voltage (RH237 fluorescence) and intracellular Ca2+ (Rhod-2 fluorescence)
from a 1 cm2 area on the right ventricular epicardial surface of an isolated perfused rat
heart, stimulated at a frequency of 5 Hz. (D) Optical imaging experiment outputs for
a single rat heart (top panels) and the corresponding simulation outputs for a “heart-
specific” model built using DT-MRI and optical imaging data from the heart in the top
panels (bottom panels). Panels left to right show activation times, action potential dura-
tion maps and action potential traces acquired from areas indicated by asterisks (aligned
by activation times). Pacing was at the site indicated by the arrow. A quantitative and
qualitative comparison of optical imaging data and simulation outputs can be used as a
means of model validation. Panels A and B from [144], panel D from [19]
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optical imaging is beyond the scope of this article, but the interested reader is1200
referred to references [8, 146] for reviews and [147, 148] for technical details.1201
In order to obtain focussed images and maintain spatial alignment over1202
time, contraction of the isolated perfused heart is usually blocked by an1203
excitation-contraction decoupler, such as blebbistatin: this results in a sta-1204
tionary heart with a geometry similar to end diastole (this compromise1205
should be accounted for when optical imaging data are interpreted). Voltage-1206
sensitive dyes, such as RH237, can then be introduced through coronary flow1207
in perfused tissue preparations, or by superfusion in smaller tissue samples.1208
These voltage-sensitive dyes bind to cardiac cell membranes and respond to1209
changes in membrane potential (i.e. the action potential) by changes in their1210
excitation and emission spectra. Spatio-temporal data acquisition of fluo-1211
rescence is usually achieved by photodiode arrays or charge-coupled device1212
(CCD) cameras. Contemporary CCD cameras readily allow high sampling1213
rates (2 kHz and more) combined with superior spatial resolution. In con-1214
ventional epi-fluorescence imaging of a perfused heart, both the light source1215
for excitation of the dye and the detector are aimed at the epicardial sur-1216
face; although fluorescence is obtained from the epicardial surface, significant1217
contributions to the fluorescent signal originate from deeper myocardial lay-1218
ers due to the optical scattering and absorptive properties of tissue with1219
respect to visible light (see [8] for details). Nevertheless, the data obtained1220
from optical imaging under a variety of pacing protocols – principally spatial1221
maps of activation times, repolarisation times, action potential durations and1222
their restitution, and conduction velocities and corresponding restitution (see1223
Fig. 14A,B) – allows partial parameterisation of tissue-level electrophysiol-1224
ogy models. For example, although conduction velocity data obtained with1225
optical imaging does not give absolute values for the components of the model1226
electrical diffusion tensor D̃ (i.e. D‖, D⊥1 and D⊥2 in equation 67), values for1227
these parameters can be scaled until the model conduction velocities (along1228
and across the myocyte axis) match those recorded using optical imaging. A1229
relatively recent development in optical imaging of the heart is the concurrent1230
recording of membrane voltage and intracellular Ca2+, through the simulta-1231
neous use of voltage- and Ca2+-sensitive dyes (such as the Ca2+-sensitive dye1232
Rhod-2) with different excitation and emission spectra [149] (Fig. 14C). As1233
with membrane potential data, the intracellular Ca2+ data obtained from1234
optical imaging can be used to parameterise the Ca2+ handling aspects of1235
the cell electrophysiology model being developed.1236
The same optical imaging data can also be used, in part, to validate1237
51
developed models. This is particularly the case when “heart-specific” mod-1238
els are constructed, where functional (electrophysiological) data from optical1239
imaging and structural data from DT-MRI are collected from the same heart1240
and these data used to construct a specific model [18] (Fig. 14D). Such1241
models are especially useful, as they allow one to study heart-specific phe-1242
nomena that may be attributable to, for example, sample-specific myocyte1243
arrangements or electrotonic interactions [19]. In these situations, the quali-1244
tative and quantitative similarities between the experimental and simulated1245
activation, repolarisation, action potential duration and conduction velocity1246
maps provides a partial validation for the developed models – see Fig. 14D.1247
In the case where both membrane voltage and intracellular Ca2+ are simul-1248
taneously mapped using optical imaging, the subsequent model validation1249
places tighter constraints on the model, as two experimental measures must1250
be simultaneously and consistently matched over both time and space.1251
5. Conclusions1252
Computational models of the heart (from cell-level models, through one-1253
, two- and three-dimensional tissue-level simplifications, to biophysically-1254
detailed three-dimensional models of the ventricles, atria or whole heart)1255
allow the simulation of excitation and propagation of this excitation, and1256
have provided remarkable insight into the normal and pathological function-1257
ing of the heart. In this article we have presented equations, along with1258
discretisation and integration schemes, and some experimental methods that1259
allow parameterisation and validation of tissue-level models, that can be1260
used to simulate cardiac electrophysiological function at the cell and tissue1261
levels. Open-source code covering the modelling presented in this article is1262
available in the Multi-scale Cardiac Simulation Framework available from1263
http://www.physicsoftheheart.com/.1264
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[108] A. Bueno-Orovio, V. Pérez-Garćıa, F. Fenton, Spectral methods1608
for partial differential equations in irregular domains: the spectral1609
smoothed boundary method, SIAM Journal on Scientific Computing1610
28 (2006) 886–900.1611
63
[109] Z. Qu, A. Garfinkel, An advanced algorithm for solving partial differen-1612
tial equation in cardiac conduction, IEEE Transactions on Biomedical1613
Engineering 46 (1999) 1166–1168.1614
[110] B. Chapman, G. Jost, R. van der Pas, Using OpenMP: Portable Shared1615
Memory Parallel Programming, The MIT Press: Cambridge, MA,1616
2008.1617
[111] P. Pacheco, Parallel Programming with MPI, Morgan Kaufmann Pub-1618
lishers, Inc: San Francisco, CA, 1997.1619
[112] S. Dokos, N. Lovell, Parameter estimation in cardiac ionic models,1620
Progress in Biophysics and Molecular Biology 85 (2004) 407–431.1621
[113] S. Niederer, E. Kerfoot, A. Benson, M. Bernabeu, O. Bernus,1622
C. Bradley, E. Cherry, R. Clayton, F. Fenton, A. Garny, E. Heidenre-1623
ich, S. Land, M. Maleckar, P. Pathmanathan, G. Plank, J. Rodŕıguez,1624
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